A Phase I clinical trial of carbon ion radiotherapy for Stage I breast cancer: clinical and pathological evaluation
Authors:
- Kumiko KarasawaKKKumiko Karasawa
- Working Group for Breast CancerWCWorking Group for Breast Cancer
Open Access
- 26 February 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Radiation Research
- Vol. 60 (3) , 342-347
Abstract
Even with its high RBE and >20 years history, there had been no breast cancer clinical trial using carbon-ion radiotherapy. We started a Phase I trial of carbon ion radiotherapy for Stage I breast cancer in 2013. This article describes the clinical and pathological evaluation of this study. Patients with low-risk Stage I breast cancer were eligible. A dose escalation study was designed, with dose levels of 48.0, 52.8 or 60.0 Gy relative biological effectiveness (RBE) administered in four fractions within 1 week. Three months after radiotherapy, the patients underwent tumor excision for pathological evaluation. Between April 2013 and December 2014, three cases receiving 48 Gy (RBE), three cases receiving 52.8 Gy (RBE) and one case receiving 60 Gy (RBE) underwent this protocol. No adverse effects were observed except for Grade 1 acute skin reaction in four cases. Pathological evaluation revealed that all four cases with doses of 52.8 Gy (RBE) and 60.0 Gy (RBE) achieved Grade 2b or more, but only two cases reached Grade 3. At the end of 2017, all cases were alive without recurrence or late had not caused any late adverse reaction. Carbon ion radiotherapy for Stage I breast cancer seems to be safe, and we found that it did not reach enough treatment effect 3 months after the treatment.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology’s
- National Institute of Radiological Sciences
This publication has 20 references indexed in Scilit:
- A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072Annals of Surgical Oncology, 2016
- First clinical experience with a dedicated MRI-guided high-intensity focused ultrasound system for breast cancer ablationEuropean Radiology, 2016
- Percutaneous Image-Guided Cryoablation of Breast Cancer: A Systematic ReviewJournal of Vascular and Interventional Radiology, 2015
- Performance analysis of a dedicated breast MR-HIFU system for tumor ablation in breast cancer patientsPhysics in Medicine & Biology, 2015
- Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experienceThe Lancet Oncology, 2015
- Magnetic resonance image-guided versus ultrasound-guided high-intensity focused ultrasound in the treatment of breast cancerChinese Journal of Cancer, 2013
- Long-term outcome of breast cancer patients treated with radiofrequency ablationEuropean Journal of Surgical Oncology, 2012
- Pilot study of radiofrequency ablation therapy without surgical excision for T1 breast cancer: evaluation with MRI and vacuum-assisted core needle biopsy and safety managementBreast Cancer, 2010
- Radiofrequency ablation as local therapy for early breast carcinomasBreast Cancer, 2010
- Ultrasound-guided Cryoablation of Invasive Ductal Carcinoma inside the MR RoomMagnetic Resonance in Medical Sciences, 2010